Turnstone Biologics Corp. (TSBX)
(Delayed Data from NSDQ)
$0.36 USD
+0.01 (1.43%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.36 +0.01 (1.41%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Turnstone Biologics Corp. has a market cap of $8.10M, which represents its share price of $0.35 multiplied by its outstanding shares number of 23.14M. As a small-cap company, TSBX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TSBX 0.36 +0.01(1.43%)
Will TSBX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TSBX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TSBX
Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock?
TSBX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TSBX
Turnstone Biologics to be acquired by XOMA Royalty
Turnstone Biologics (TSBX) Agrees to Acquisition by XOMA Royalty | TSBX Stock News
Xoma to acquire Turnstone Biologics for $0.34 in cash per share
Xoma to acquire Turnstone Biologics for $0.34 in cash per share
Turnstone Biologics Corp. Enters Merger Agreement with XOMA